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Abstract
Background: Propofol is a widely used intravenous anesthetic that is well-known for its protective effect in various
human and animal disease models. However, the effects of propofol on neurogenesis, especially on the development
of neural stem cells (NSCs), remains unknown. Related microRNAs may act as important regulators in this process.
Methods: Published Gene Expression Omnibus (GEO) DataSets related to propofol were selected and re-analyzed to
screen neural development-related genes and predict microRNA (miRNA) expression using bioinformatic methods.
Screening of the genes and miRNAs was then validated by qRT-PCR analysis of propofol-treated primary embryonic NSCs.
Results: Four differentially expressed mRNAs were identified in the screen and 19 miRNAs were predicted based
on a published GEO DataSet. Two of four mRNAs and four of 19 predicted miRNAs were validated by qRT-PCR
analysis of propofol-treated NSCs. Rno-miR-19a (Rno, Rattus Norvegicus) and rno-miR-137, and their target gene
EGR2, as well as rno-miR-19b-2 and rno-miR-214 and their target gene ARC were found to be closely related to
neural developmental processes, including proliferation, differentiation, and maturation of NSCs.
Conclusion: Propofol influences miRNA expression; however, further studies are required to elucidate the mechanism
underlying the effects of propofol on the four miRNAs and their target genes identified in this study. In particular, the
influence of propofol on the entire development process of NSCs remains to be clarified.
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Background
Propofol, a rapid onset intravenous anesthetic, is widely
used in general anesthesia induction and maintenance, sed-
ation in intensive care unit (ICU) settings and in various
kinds of examinations, such as gastroscopy and pediatric
imaging examinations because of its ease of control and
comfort recovery attributes. Propofol is also well-known for
its neuroprotective effects derived from its anti-oxidant and
anti-inflammatory properties. These effects have been
demonstrated in a number of different disease models, in-
cluding post-cardiac arrest brain injury [1] and cerebral is-
chemia/reperfusion injury [2], in which propofol inhibits
the activation of microglia and apoptosis-inducing factor
pathway [1, 2] and decreases the production of inflamma-
tory factors [3]. However, there are concerns about the
neurotoxicity of propofol. Yu et al. [4] reported that re-
peated exposure to propofol induced exposure-time-
dependent neuronal cell loss and long-term neurocognitive
deficits in neonatal rats. Twaroski et al. [5] also demon-
strated that propofol induced cell death of human stem
cell-derived neurons via a mitochondrial fission/mPTP-me-
diated pathway. The mechanisms by which propofol pro-
duce neuroprotective or neurotoxic effects are still unclear
although the effect of propofol on neurogenesis is a focus
of research. Based on a rodent cerebral ischemia/reperfu-
sion model, some studies [6, 7] suggested that propofol
post-conditioning can promote neurogenesis in the dentate
gyrus of the hippocampus, leading to long-term neuropro-
tection. Interestingly, Engelhard et al. [8, 9] found that
propofol may have a minor independent effect on neuro-
genesis via a cerebral ischemia rat model in 2009, whereas
they also demonstrated the toxic effect of propofol on
neurogenesis through a traumatic brain injury rat model in
2014. Additionally, Krzisch et al. [10] and Huang et al. [11]
provided evidence of the detrimental effects of propofol on
adult and early postnatal hippocampus neurogenesis. These
controversial results indicating both neuroprotective and
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neurotoxic effects of propofol may be due not only to the
different animal model used by these studies, but also the
complexity of the neurogenic process.
MicroRNAs (miRNAs) are small (22–24 nucleotides)
non-coding RNAs, which can be incorporated into the
RNA-induced silencing complex (RISC) to form the
miRNA-loaded RISC (miRISC). Furthermore, the miRISC
can bind the 3′ or 5′ untranslated region (UTR) of target
mRNAs to induce RNA-based gene silencing. A number of
miRNAs have been shown to be related to nervous system
development. For example, miR-7 inhibits the NLRP3/cas-
pase-1 axis in adult neural stem cells (NSCs) to promote
subventricular zone neurogenesis [12]. MiR-124 and miR-
137 affect early neurogenic response through cooperative
control of caspase-3 activity [13]. MiR-17/106 targets p38
to modulate neural stem/progenitor cell multipotency [14].
MiR-19 of the miR-17–92 cluster promotes NSC prolifera-
tion [15] and targets FoxO1 to regulate NSC differentiation
through cooperation with the Notch signaling pathway
[16]. MiR-128, miR-132, miR-134, and miR-138 have also
been shown to be involved in NSC maturation and den-
dritic spine morphogenesis [17]. In combination, these data
suggest that miRNAs act as not merely as a fine tuning sys-
tem, but also as key regulators in the development of NSCs
during neurogenesis [18]. These findings represent a prom-
ising and challenging area of research in the field of
anesthesiology. Recently, several investigations showed that
miRNAs play pivotal roles in anesthetic-induced neurotox-
icity. Twaroski et al. [19] indicated the involvement of miR-
21 in propofol-induced cell death via the STAT3/Sprouty-2
pathway using human stem cell-derived neurons. MiR-137,
miR-124, miR-34a, and miR-34c have also been implicated
in ketamine-induced neurotoxicity in various in vivo and in
vitro models [20–23]. Recently, miR-9 was shown to be in-
volved in the inhibition of embryonic stem cell self-renewal
and neural differentiation following exposure to the inhaled
anesthetic isoflurane [24]. Another investigation also indi-
cated that anxiety-like disorders caused by postnatal expos-
ure to sevoflurane may be related to miR-632, which
targets BDNF and a voltage dependent calcium channel
[25]. These recent investigations suggest a novel miR-
related mechanism responsible for the neurotoxicity of pro-
pofol, ketamine, isoflurane and sevoflurane in various in
vitro and in vivo models. However, the precise mechanisms
are still poorly understood.
In our previous study [26, 27], we found that propofol
promotes adult NSC proliferation in vitro but impairs
the learning and memory ability of the rats, which may
be related to decreased dentate gyrus neurogenesis in
the rat hippocampus. Our results, which are consistent
with those reported by Krzisch et al. [10], indicated that
propofol may have a negative effect on neurogenesis.
The development of NSCs in the dentate gyrus, which is
a region of neurogenesis in adults, is closely associated
with memory and learning ability. Nevertheless, the
causes of this apparent contradiction between our previ-
ous in vitro and in vivo studies remain to be determined.
We hypothesized that miRNAs act as key regulators in
these processes; therefore, in this study, we aimed to
identify miRNAs that are differentially expressed follow-
ing exposure to propofol using a non-traditional method
based on in-depth analysis of published GEO Datasets.
As a result, we confirmed differential expression of four
miRNAs in response to propofol treatment.
Methods
Microarray datasets and data selection
The Gene Expression Omnibus (GEO) DataSets (http://
www.ncbi.nlm.nih.gov/gds) were searched to identify
datasets from recent studies (until 06/30/2015) related
to propofol anesthesia or sedation in mammalian species
and performed using up-to-date whole-genome se-
quence or microarray chips. We found only one dataset
(GEO# GSE4386; Series published: 1/1/2007) [28]. Fur-
ther data were selected from a total of 10 datasets re-
ported for patients who underwent propofol anesthesia
(Table 1). Based on these 10 datasets, the following
strategies were used to search the GEO Profiles (http://
www.ncbi.nlm.nih.gov/geoprofiles/): 1) propofol and
hippocampus; 2) propofol and neural stem cell; 3) pro-
pofol and neural stem cell and proliferation; 4) propofol
and neural stem cell and differentiation; 5) propofol and
neural stem cell and maturation; 6) propofol and neural
stem cell and migration; 7) propofol and plasticity; 8)
propofol and nerve system development; 9) propofol and
brain development; and 10) propofol and learning and
memory. The gene list and expression levels were then
downloaded from GEO Profiles for further analysis.
Data screening, bioinformatic analysis and validation
The paired samples of microarray expression data ob-
tained at the beginning and end of bypass surgery from
the datasets for the 10 patients were screened according
to the following criteria: 1) fold-change in gene expres-
sion ≥1.5; 2) fold-change in gene expression ≥1.5 in at
Table 1 Selected GO biological function and involved genes
GO Term GO name P-value Genes
GO:0048167 Regulation of synaptic
plasticity
3.20E-06 EGR1, ARC, EGR2,
PTGS2, SNCA
GO:0048168 Regulation of neuronal
synaptic plasticity
3.37E-05 EGR1, ARC, EGR2,
SNCA
GO:0021675 Nerve development 4.84E-04 HOXB3, HES1, EGR2
GO:0007611 Learning or memory 6.42E-04 EGR1, EGR2, PTGS2,
TAC1
GO:0030182 Neuron differentiation 0.002551 HES1, EGR2, CXCR4,
PHGDH, ID4
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least 5 samples; and 3) identical trend of gene expression
in the samples. The average fold-change in the expres-
sion of the screened genes for each sample were then
compiled, and matrix self-organizing map-based cluster-
ing analysis of relative gene expression was performed
using the R Program.
The screened genes were analyzed by DAVID [29] (the
Database for Annotation, Visualization and Integrated
Discovery), which is a bioinformatics resource comprising
gene and protein annotation databases and several analyt-
ical tools for extracting biological relationships from a list
of genes. The functional annotation tool of DAVID was
used to analyze gene ontology biological function terms
enrichment. The genes related in GO terms to neurodeve-
lopment, neural plasticity, learning and memory at P <
0.05 were selected for further screening. The frequency of
each gene in the selected biological process was deter-
mined and genes with frequencies ≥2 were analyzed using
the blastn suite of BLAST. The genes with identities
≥85 % between humans and rats were finally selected for
qRT-PCR validation.
MiRNA prediction and screening
MiRWalk2.0 is a comprehensive archive providing a
collection of predicted and experimentally verified
miR-target interactions with various miRNA databases
[30]. The miRNAs which can target the validated
genes are predicted using the gene-miRNA interaction
information retrieval system of the predicted target
module in miRWalk2.0 based on the following data-
bases: miRWalk, miRanda, miRDB and TargetScan.
The miRNAs predicted by all four databases were se-
lected for qRT-PCR validation.
Primary NSC culture and propofol treatment
Time mated pregnant Sprague Dawley rats were anes-
thetized at gestation day 14 using isoflurane prior to
euthanization by cervical dislocation to minimize pain
and distress. The embryos were collected, and the cortex
and hippocampus of the embryo brains were dissected
under a microscope. All animal procedures were ap-
proved and conducted in accordance with the guidelines
for the care and use of animals of the ethics committee
of Southern Medical University. The tissues were the ho-
mogenized, digested by Accutase (Millipore, Darmstadt,
Germany) and suspended with NSC basal medium
(Millipore, Darmstadt, Germany) to form a single cell
suspension (2 × 106 cells/ml). The cells were cultured in
the NSC basal medium containing 20 ng/ml basic fibro-
blast growth factor (bFGF; Peprotech, Rocky Hill, USA)
and 20 ng/ml epidermal growth factor (EGF; Peprotech,
Rocky Hill, USA), and then incubated at 37 °C under
5 % CO2 to form neurospheres. At 150–200 μm in
diameter, the neurospheres were dispersed into single
cells by treatment with Accutase and suspended at the
density of 5 × 105 cells/ml. Subsequently, the NSCs were
seeded in culture plates or dishes pre-coated with 25 μg/
ml poly L-ornithine (Sigma–Aldrich, St. Louis, MO,
USA) and cultured for 2–3 days for use in further exper-
iments. The culture medium was then replaced with
fresh medium supplemented with 100 mM 2,6-diisopro-
pylphenol (propofol) (Sigma–Aldrich) dissolved in di-
methyl sulfoxide (DMSO) (Sigma–Aldrich) at a final
concentration of 50 μM. The same procedures were per-
formed using DMSO alone in the control group. The
cells were treated for 6 h before being harvested for total
RNA extraction at the following time-points: immedi-
ately (T1), Day 1 (T2), Day 3 (T3) and Day 7 (T4) after
treatment with propofol.
Immunocytochemistry
The neurospheres and NSCs were identified by immuno-
cytochemistry and the proportion of NSCs was determined
by cell counting. The cells were washed once with
phosphate-buffered saline (PBS) and fixed for 30 min at
room temperature in 4 % paraformaldehyde (Solarbio,
Beijing, China) and then 15 min in 0.25 % Triton X-100
(Sigma–Aldrich). After washing three times with PBS, the
cells were blocked for 1 h at room temperature in 2 % bo-
vine serum albumin (BSA) (Solarbio) before incubation
overnight at 4 °C with anti-nestin (1:300) (Abclonal, Boston,
USA) for the detection of NSC as a specific marker of
NSCs. The cells were washed three times (10 min each)
with PBS and incubated for 1 h at room temperature with
FITC-conjugated goat anti-mouse (1:500) (Proteintech,
Chicago, IL, USA) secondary antibodies. After the NSCs
were washed 3–4 times (5 min each) with PBS, nuclei were
counterstained with DAPI (Vectorlabs, Burlingame, CA,
USA). Finally, the cells were mounted onto glass slides and
imaged using a laser-scanning confocal microscope (Olym-
pus FV10i, Tokyo, Japan) for cell counting using previously
described protocols [24]. Briefly, nuclei were counted in five
fields per well (center and at the 3, 6, 9, and 12 o’clock posi-
tions). Each field contained >100 cells. Nestin-positive and
DAPI-positive cells were counted and summed for dupli-
cate wells in three independent experiments. The propor-
tion of NSCs (percentage of NSCs) was calculated as the
number of nestin and DAPI double-positive cells divided
by the total cells counted ×100 %. Cell numbers were
counted by an investigator who was blinded with respect to
the sample identity.
Total RNA extraction and qRT-PCR
Total RNA was isolated from the primary NSCs using
TRIzol reagent (ThermoFisher, Waltham, MA, USA) fol-
lowing the manufacturer’s protocol and 1 μg of RNA was
used to synthesize cDNA with SuperScriptase III
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(ThermoFisher) using random primers for mRNA ana-
lysis. MiRNAs were isolated using RNAiso for small RNA
(TaKaRa, Dalian, China) following the manufacturer’s
protocol and 5 μg of RNA was polyadenylated and used to
synthesize cDNA with the MirX miRNA First Strand Syn-
thesis kit (Clontech, Nojihigashi, Japan). Expression of
mRNA and miRNA was determined by quantitative real-
time PCR (qPCR) using the SYBR Green PCR Kit (Qiagen,
Duesseldorf, Germany) and MirX miRNA qRT-PCR SYBR
Kit (Clontech, Nojihigashi, Japan), respectively. qPCR was
performed on the Stratagene Mx3000P Real-Time PCR
System (Agilent, Santa Clara, USA) with the following
conditions: denaturation at 95 °C for 10 s, followed by
40 cycles of 95 °C for 5 s and 60 °C for 20 s. Three bio-
logical samples were each tested in triplicate for each sam-
ple. All experiments were repeated three times. GAPDH
and U6 were used as endogenous controls for mRNA and
miRNA analysis, respectively. The primers sequences used
in this analysis are shown in Additional file 1: Table S3.
Changes in relative expression were determined using the
second derivative maximum method 2-ΔCT calculated by
subtracting the cycle threshold (CT) of the endogenous
control gene from the CT of the gene of target. Relative
fold-changes were calculated using the 2-ΔΔCT method.
Statistical analysis
Data analysis was performed using SPSS 19.0 software.
Data were expressed as mean ± standard deviation (SD).
The expression of miRNAs and mRNAs at each time-
point was assessed using Student’s t-test. P values < 0.05
were considered to indicate statistical significance.
Results
Candidate genes related to propofol exposure
Based on the search strategies, a total of 420 different
genes (Additional file 2: Table S1) that related to propo-
fol exposure were selected when duplicates were ex-
cluded and their expression data were downloaded from
the GEO Profiles.
In total, the expression patterns of 19 genes (12 upreg-
ulated and 7 downregulated) fulfilled the screening cri-
teria (Fig. 1). We then used DAVID to analyze the gene
ontology biological function of the 19 genes. The genes
were predicted to be involved in 124 biological functions
(Additional file 3: Table S2). Five of these biological
functions were related to neurodevelopment, neural
plasticity, learning and memory; 11 genes involved in
these biological functions were selected for subsequent
screening (Table 1). Of these, four genes (EGR1, EGR2,
HES1 and ARC) were selected for qRT-PCR validation
based on the frequency in the selected biological func-
tions and BLAST identity (Table 2) (Fig. 2).
Candidate gene expression in propofol-treated NSCs
Immunocytochemical evaluation showed that the pri-
mary cultured neurospheres and NSCs were stained
nestin-positive (Fig. 3a). The cell count confirmed that
the average proportion of primary cultured NSCs was
(91.33 ± 2.24)% (Fig. 3b). Following treatment with pro-
pofol for 6 h, significant differential expression of EGR2
and ARC compared with the DMSO control was ob-
served at the four time-points (Fig. 4a and b) whereas
there was no significant difference in HES1 and EGR1
Fig. 1 Expression level and number of differentially expressed genes induced by propofol anesthesia. a Heatmap of differentially expressed genes
induced by propofol anesthesia. Green and red represent decreased and increased expression, respectively, relative to the average expression in
blood samples from patients who received propofol anesthesia. b The number of upregulated (red) and downregulated (green) genes
Fan et al. BMC Anesthesiology  (2016) 16:95 Page 4 of 11
expression levels compared with the DMSO control
(Fig. 4c and d). Additionally, the fold-change in average
relative expression of EGR2 and ARC ranged from 2.58
to 4.38 and 3.48 to 14.76, respectively (Table 3).
MiRNA prediction and expression in propofol-treated
NSCs
By searching the four databases (miRWalk, miRanda,
miRDB and TargetScan), 248 and 346 miRNAs (Additional
file 4: Table S4) were predicted to target the 3′ UTRs of
EGR2 and ARC, respectively. The miRNAs predicted by all
four databases (rno-miR-19b-2, rno-miR-137, rno-miR-19a
and rno-miR-214, (Rno, Rattus Norvegicus)) were selected
for validation (Table 4 and Fig. 5).
Following treatment with propofol for 6 h, significant
differential expression of the four selected miRNAs com-
pared with the DMSO control was observed the four
time-points (Fig. 6). Rno-miR-19a, rno-miR-19b-2 and
rno-miR-214 were downregulated at all four time-points,
while rno-miR-137 was downregulated at T1 followed by
upregulation from T2 to T4 (Fig. 6). The fold-change in
the mean expression levels of rno-miR-19b-2, rno-miR-
137, rno-miR-19a and rno-miR-214 ranged from -2.56 to
-12.15, -2.02 to 4.61, -2.33 to -6.68 and -2.16 to -4.63, re-
spectively (Table 5).
Discussion
In the current search of PubMed, we found no more
than 25 articles directly related to the interaction
between propofol and miRNAs. Two of these [31, 32]
described the miRNA expression profiles of rat hippo-
campus and cortex after propofol and sevoflurane
anesthesia. In two articles by Pei et al., one described the
miRNA expression profiles of developing rat hypocam-
pal astrocytes after propofol treatment [33] and the sec-
ond reported that propofol upregulates rno-miR-665
expression to induce apoptosis in developing hippocam-
pal astrocytes via a rno-miR-665/BLC2L1/caspase-3-me-
diated mechanism [34]. Gomez-Martin et al. [35]
suggested that propofol induces death in the neurons
derived from human stem cells and downregulates miR-
21 via a mechanism that is likely to involve STAT3 acti-
vation and Akt downregulation. These results provide
evidence that propofol treatment causes changes in
miRNA expression. However, as of the end of July 2016,
there are no reports describing the effect of propofol on
miRNA expression in NSCs.
EGR2 (early growth response-2), which is a member of
the EGR family, acts as a key regulator in immune toler-
ance [36]. The function of EGR2 in NSCs is still unknown.
Parkinson et al. found that EGR2 (Krox-20) expression ex-
erts a strong protective effect against cells apoptosis and





EGR2 4 UP NM_001136177 NM_053633 0.87
EGR1 2 UP NM_001964 NM_012551 0.86
HES1 2 UP NM_005524 NM_024360 0.90
ARC 2 UP NM_015193 XM_008765591 0.86
Fig. 2 Enrichment of the top 25 biological processes in gene ontology analysis. –LgP is the negative logarithm of the P-value, with higher –LgP
values indicating greater significance of the biological process
Fan et al. BMC Anesthesiology  (2016) 16:95 Page 5 of 11
Fig. 3 Identification of primary cultured neural spheres and neural stem cells. a Neural spheres and neural stem cells were immunostained with
anti-nestin antibody (green) and counterstained with DAPI (blue). b Purity of primary cultured neural stem cells calculated by cell counting
Fig. 4 Quantitative RT-PCR analysis of relative EGR2, ARC, HES1 and EGR1 expression. Relative expression levels of EGR2, ARC, HES1 and EGR1 at
all four time-points (immediately (T1), Day 1 (T2), Day 3 (T3) and Day 7 (T4) after treatment with propofol or DMSO). *P < 0.05, compared with the
DMSO control group at each time-point
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safeguards Schwann cells from death by growth factor
deprivation [36]. This result is consistent with those of our
previous study showing that propofol treatment reduces
apoptosis and promotes proliferation of adult NSCs [26].
In our current study, EGR2 mRNA in NSCs was elevated
immediately after treatment with propofol for 6 h and this
upregulation persisted to 7 days after treatment. Therefore,
we speculate that the elevated EGR2 expression may con-
tribute partly to the proliferation of NSCs observed in vitro
in our previous report [26]. On the other hand, the de-
crease in neurogenesis reported both by Krzisch et al. [10]
and ourselves [27] may result partly from EGR2 upregula-
tion, which promotes myelination and induces NSC differ-
entiation into oligodendrocytes in the central nervous
system. Of the two miRNAs predicted to target EGR2,
miR-19b was downregulated, which in accordance with the
increased expression of EGR2, while miR-137 was down-
regulated only at T1 followed by upregulation from T2 to
T4. MiR-19b is a member of miR-19 family located in the
miR-106–25 cluster, which has been reported to be
involved in regulating NSC proliferation and differentiation
through a network related to the insulin/IGF-FoxO path-
way [37]. MiR-137 is a versatile miRNA that plays different
roles in the proliferation, differentiation and maturation of
NSCs. Shi et al. found that miR-137 exerts a negative effect
on proliferation of embryonic NSCs and then accelerates
differentiation via a feedback regulatory loop with TLX and
LSD1 [38]. A previous study also demonstrated that miR-
137 promotes proliferation and represses differentiation of
NSCs by targeting Ezh2 [39] and regulates NSC matur-
ation by targeting mind bomb-1 [40]. The expression pat-
terns obtained in the present study combined with the
results of these previous reports indicate that miR-19b and
miR-137 interact with EGR2 to promote proliferation and
repress the differentiation of NSCs. However, the potential
relationship between EGR2 and miR-19b/miR-137 on the
development of NSCs remains to be fully elucidated.
ARC (activity-regulated cytoskeleton-associated protein)
is another key factor in early embryonic development. As a
member of the immediate-early gene (IEG) family, ARC
plays a critical role in learning, memory consolidation [41]
and synaptic plasticity [42] and acts as a regulator in cell
morphology, cytoskeletal organization and cell migration
[43]. The activation of cAMP promotes ARC expression
[44, 45]. The upregulation of ARC expression observed in
our present study may be due to the propofol induced
CREB phosphorylation that we reported previously [26].
Furthermore, we observed downregulated expression of
miR-19a and miR-214, which are predicted to target ARC.
MiR-19a is located in the miR-17–92 cluster, which pro-
motes the NSC proliferation via repression of PTEN [15].
Another study conducted in a murine stroke model con-
firmed that miR-19a upregulation promotes NSC prolifera-
tion by targeting PTEN [46]. MiR-214 is located in the
miR-199a–214 cluster and targets PTEN to produce a pro-
tective effect in cardiac myocytes against H2O2-induced in-
jury [47]. Lee et al. reported that miR-214 may act as a
novel intermediator in controlling the NSC development
[48]. Recently, Huat et al. [49] found that the miR-214 was
downregulated during the development of neural
progenitor-like cell derived from rat bone marrow mesen-
chymal stem cell induced by IGF-1, bFGF and EGF. It can
be speculated that the increased expression of ARC in
NSCs following exposure to propofol will have a beneficial
effect, which is in conflict with the neurotoxic effects of
propofol in vivo reported by Krzisch et al. [10] Further-
more, when combined the patterns of miR-19a and miR-
214 expression, the situation is much more complex and
the results are somewhat contradictory. Clearly more so-
phisticated studies are required to explain these paradoxical
phenomena and the underlying mechanism.
In this study, we did not adopt the traditional approach
of miRNA sequencing or miRNA array analysis to screen
the differences in miRNA expression of NSCs after
Table 3 Fold change of EGR2 and ARC expression at four
time-points
Gene T1 T2 T3 T4
EGR2 3.37 2.58 4.38 2.64
ARC 3.48 5.41 14.76 9.57
Table 4 Information for microRNAs predicted by four databases
to target EGR2 or ARC
Gene Entrez ID Refseq ID MiRNA MIMATid
EGR2 114090 NM_053633 rno-miR-7a-1-3p MIMAT0000607
EGR2 114090 NM_053633 rno-miR-3572 MIMAT0017853
EGR2 114090 NM_053633 rno-miR-376b-5p MIMAT0003195
EGR2 114090 NM_053633 rno-miR-376c-5p MIMAT0017219
EGR2 114090 NM_053633 rno-miR-145-5p MIMAT0000851
EGR2 114090 NM_053633 rno-miR-19b-2-5p MIMAT0017097
EGR2 114090 NM_053633 rno-miR-3591 MIMAT0017893
EGR2 114090 NM_053633 rno-miR-186-3p MIMAT0017143
EGR2 114090 NM_053633 rno-miR-3065-5p MIMAT0017839
EGR2 114090 NM_053633 rno-miR-150-5p MIMAT0000853
EGR2 114090 NM_053633 rno-miR-137-3p MIMAT0000843
EGR2 114090 NM_053633 rno-miR-224-5p MIMAT0003119
ARC 54323 NM_019361 rno-miR-19b-3p MIMAT0000788
ARC 54323 NM_019361 rno-miR-664-2-5p MIMAT0017229
ARC 54323 NM_019361 rno-miR-219b MIMAT0017882
ARC 54323 NM_019361 rno-miR-214-3p MIMAT0000885
ARC 54323 NM_019361 rno-miR-632 MIMAT0012837
ARC 54323 NM_019361 rno-miR-19a-3p MIMAT0000789
ARC 54323 NM_019361 rno-miR-664-1-5p MIMAT0017228
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propofol treatment. Instead, we developed a method based
on re-analysis of a published GEO DataSet from a study
which aimed to identify myocardial transcriptional pheno-
types after propofol and sevoflurane anesthesia to predict
cardiovascular biomarkers and function in patients under-
going off-pump coronary artery bypass graft surgery [28].
In that study, the authors compared and analyzed the
different gene expression profiles of blood samples biop-
sied from two time-points, at the beginning and at end of
the surgery. Therefore, we hypothesized that most of these
genes are also expressed by brain tissue and designed a set
of criteria to screen or predict the NSC-related genes or
miRNAs. In our study, four candidate mRNAs and 19
candidate miRNAs were selected for qRT-PCR validation.
Fig. 5 Venn diagram showing the microRNAs predicted to target EGR2 and ARC in the different databases. The digits in the two red circles
represent the number of microRNAs predicted by all of four databases simultaneously
Fig. 6 Quantitative RT-PCR analysis of relative expression levels of rno-miR-19b-2, rno-miR-137, rno-miR-19a and rno-miR-214. Relative expression
levels of rno-miR-19b-2, rno-miR-137, rno-miR-19a and rno-miR-214 at all four time-points (immediately (T1), Day 1 (T2), Day 3 (T3) and Day 7 (T4)
after treatment with propofol or DMSO). *P < 0.05, compared with the DMSO control group at each time-point
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In this way, we confirmed two genes (EGR2 and ARC)
and four miRNAs (rno-miR-19a, rno-miR-137, rno-miR-
19b-2 and rno-miR-214) that exhibited at least a 2-fold
change in the mean expression level following propofol
treatment at all four time-points. In recent years, with the
development of the next generation sequencing and chip
array techniques combined with advances in bioinformat-
ics, a great deal of data has been accumulated in relation
to various physiological or pathological conditions. The
potential value of these data has yet to be exploited fully.
Our study provides a new method for re-use and re-
analysis of these data for more effective and efficient
application in different areas of research. In particular,
publication of these data provides invaluable information
for research groups with limited financial resources.
The results of the present study indicate that propofol
may have the ability to regulate the expression of rno-
miR-19a, rno-miR-137, rno-miR-19b-2 and rno-miR-214
and their target genes, ARC and EGR2. Additionally, this
effect may last for at least 7 days after propofol expos-
ure. However, the specific mechanism of these effects
require further investigation, with particular reference
the entire process of NSC development.
Conclusion
The expression of four miRNAs (rno-miR-19a, rno-miR-
137, rno-miR-19b-2 and rno-miR-214) and their target
genes (EGR2 and ARC) were shown to be regulated by
propofol in primary cultured embryonic NSCs. The
underlying mechanism requires elucidation in more so-
phisticated studies.
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